Spotlight Therapeutics, Inc.

Biotechnology company · Hayward, California, United States

Spotlight Therapeutics, Inc. is a biotechnology company headquartered in Hayward, California, United States. Its earliest recorded incorporation is in 2017. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $32 million sold in a notice filed in 2022.

www.spotlighttx.comProfile compiled from public records. Is this your company? Request a correction or update

Spotlight Therapeutics at a glance

Typebiotechnology company
HeadquartersHayward, California, United States
Earliest incorporation on record2017
Employees (self-reported, 2023)34
SEC CIK1726495

What does Spotlight Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $1 million in total (2023). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $32.2 million sold (2022).

Frequently asked questions about Spotlight Therapeutics

Where is Spotlight Therapeutics headquartered?

Spotlight Therapeutics, Inc. is headquartered in Hayward, California, United States.

What does Spotlight Therapeutics do?

Spotlight Therapeutics, Inc. is a biotechnology company.

When was Spotlight Therapeutics founded?

The earliest incorporation on record for Spotlight Therapeutics, Inc. is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences